Trial Profile
A phase III trial of topical capsaicin liquid (NGX 1998) for the treatment of neuropathic pain conditions.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 08 May 2012
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Registrational; Therapeutic Use
- 08 May 2012 New trial record